Similarly, the Women’s Health Initiative Observational Study (WHI-OS) of 93,676 postmenopausal women, insulin levels were associated with a > 2.4-fold increase in breast cancer risk in women not on hormone-replacement therapy [55]. This evidence concerns the gene INS and breast cancer.